MYCOBACTERIUM ABSCESSUS INFECTION
Clinical trials for MYCOBACTERIUM ABSCESSUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new MYCOBACTERIUM ABSCESSUS INFECTION trials appear
Sign up with your email to follow new studies for MYCOBACTERIUM ABSCESSUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental virus therapy targets stubborn lung infection in single patient
Disease control ENROLLING_BY_INVITATIONThis study tests a special virus (bacteriophage) designed to attack a tough lung infection caused by Mycobacterium abscessus. The treatment is given alongside standard antibiotics to one patient. The goal is to see if the virus can help clear the infection and improve lung health…
Matched conditions: MYCOBACTERIUM ABSCESSUS INFECTION
Phase: PHASE1 • Sponsor: Vancouver Coastal Health • Aim: Disease control
Last updated May 07, 2026 18:41 UTC
-
New hope against drug-resistant lung bug: contezolid shows early promise
Disease control ENROLLING_BY_INVITATIONThis study tests a new antibiotic called contezolid in 24 adults with a stubborn lung infection caused by Mycobacterium abscessus. Participants take the drug alone for 14 days, and researchers measure how much the bacteria level drops in their sputum compared to a standard antibi…
Matched conditions: MYCOBACTERIUM ABSCESSUS INFECTION
Phase: PHASE2 • Sponsor: Beijing Chest Hospital • Aim: Disease control
Last updated Apr 29, 2026 15:15 UTC